Recent Paradigm Shifts in the Diagnosis and Treatment of Rheumatoid Arthritis

Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome

(2011) Lilian H D van Tuyl et al.   ANNALS OF THE RHEUMATIC DISEASES

Established rheumatoid arthritis: Rationale for best practice – Physicians’ perspective of how to realise tight control in clinical practice

(2011) S.C. Horton et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Assessment of control of rheumatoid arthritis disease activity

(2011) Karen I. Salomon-Escoto et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Monitoring rheumatoid arthritis

(2011) Josef S Smolen et al.   CURRENT OPINION IN RHEUMATOLOGY

New therapies in the management of rheumatoid arthritis

(2011) Maya H Buch et al.   CURRENT OPINION IN RHEUMATOLOGY

The Pathogenesis of Rheumatoid Arthritis

(2011) Iain B. McInnes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

(2011) Yoshiya Tanaka et al.   ARTHRITIS CARE & RESEARCH

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

(2011) Patricia Guyot et al.   ARTHRITIS RESEARCH & THERAPY

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

(2010) Michael E. Weinblatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

(2010) W. Hueber et al.   Science Translational Medicine

Inflammatory Polyarthritis in a Patient with Psoriasis: Is It Psoriatic Arthritis or Rheumatoid Arthrirtis?

(2010) Kwang-Hoon Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis

(2010) Steven S. Storage et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis

(2009) Rohit Aggarwal et al.   ARTHRITIS AND RHEUMATISM

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

(2009) Joel M. Kremer et al.   ARTHRITIS AND RHEUMATISM

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review

(2009) Paul A. Monach et al.   ARTHRITIS AND RHEUMATISM

Interleukin-17 and Type 17 Helper T Cells

(2009) Pierre Miossec et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints

(2008) K Polzer et al.   ANNALS OF THE RHEUMATIC DISEASES